Pairing that with our new microdose GLP-1 program will help bend the curve on obesity rates in the United States. The launch of Nooms microdose program comes as drugmakers race to expand the obesity treatment market with new (and sometimes needle-free) options
Using them may promote mild weight loss results
More studies are needed, though, to confirm the aforementioned taste-altering findings and determine how common taste changes and dysgeusia may be
Engaging in informed discussion with your healthcare provider is essential for determining whether GLP-1 therapy is appropriate for you and, if so, which specific agent best aligns with your clinical needs and personal preferences
Instead of following traditional dosing schedules designed to reach higher maintenance doses, some individuals are exploring lower-dose approaches with the goal of achieving appetite control while minimizing side effects
It describes protocols that place the dose roughly thirty minutes ahead of food